Max Chan
Finanzdirektor/CFO bei FORESEE PHARMACEUTICALS CO., LTD.
Aktive Positionen von Max Chan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| JHL BIOTECH, INC. | Comptroller/Controller/Auditor | 20.10.2015 | - |
| Finanzdirektor/CFO | 20.10.2015 | 01.05.2018 | |
| FORESEE PHARMACEUTICALS CO., LTD. | Finanzdirektor/CFO | 07.10.2019 | - |
| Public Communications Contact | 07.10.2019 | - | |
| Himax Taiwan, Inc. | Finanzdirektor/CFO | 08.03.2010 | - |
| Himax Media Solutions, Inc. | Direktor/Vorstandsmitglied | 08.03.2010 | - |
| Himax Imaging Ltd. | Direktor/Vorstandsmitglied | 08.03.2010 | - |
Wisepal Technologies, Inc.
 Wisepal Technologies, Inc. Electronics DistributorsDistribution Services Part of Himax Technologies, Inc., Wisepal Technologies, Inc. is a Taiwanese company that manufactures display drivers. The company is based in Miao-Li, Taiwan. Wisepal Technologies was acquired by Himax Technologies, Inc. on February 01, 2007 for $21.52 million. | Direktor/Vorstandsmitglied | 08.03.2010 | - |
| Harvest Investments Ltd. | Direktor/Vorstandsmitglied | 09.12.2010 | - |
| Himax Semiconductor Ltd. | Direktor/Vorstandsmitglied | 09.12.2010 | - |
Karriereverlauf von Max Chan
Ehemalige bekannte Positionen von Max Chan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OBI PHARMA, INC. | Geschäftsführer | 01.01.2010 | - |
| Finanzdirektor/CFO | 01.01.2010 | 01.01.2019 | |
| Public Communications Contact | 01.01.2010 | 01.01.2019 | |
| Corporate Officer/Principal | 01.01.2010 | - | |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Max Chan
| National Taiwan University | Masters Business Admin |
| University of Illinois | Graduate Degree |
Statistik
International
| Taiwan | 13 |
| Vereinigte Staaten | 3 |
| Vereinigtes Königreich | 2 |
Operativ
| Director of Finance/CFO | 6 |
| Director/Board Member | 5 |
| Corporate Officer/Principal | 4 |
Sektoral
| Health Technology | 5 |
| Electronic Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| HIMAX TECHNOLOGIES, INC. | Electronic Technology |
| INTEL CORPORATION | Electronic Technology |
| OBI PHARMA, INC. | Health Technology |
| FORESEE PHARMACEUTICALS CO., LTD. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
| Himax Taiwan, Inc. | |
| Himax Media Solutions, Inc. | |
| Himax Imaging Ltd. | |
Wisepal Technologies, Inc.
Wisepal Technologies, Inc. Electronics DistributorsDistribution Services Part of Himax Technologies, Inc., Wisepal Technologies, Inc. is a Taiwanese company that manufactures display drivers. The company is based in Miao-Li, Taiwan. Wisepal Technologies was acquired by Himax Technologies, Inc. on February 01, 2007 for $21.52 million. | Distribution Services |
| Harvest Investments Ltd. | |
| Himax Semiconductor Ltd. | |
| Credit Suisse First Boston Asia International (Cayman) Ltd. | |
CDIB Capital Group
 CDIB Capital Group Investment ManagersFinance CDIB Capital Group engages in the venture capital, and investment banking industries. Its business activities include industrial investment, asset management, own capital investment assets, activated assets, and international investment. The company was founded in 1959 and is headquartered in Taipei, Taiwan. | Finance |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
